Michael Torres | BiotechTV

top of page

ASGCT 2026: Michael Torres isn't slowing down after selling his antibody-drug conjugate company to Eli Lilly. Here's his gene therapy play

He describes the work he is involved in with ARTAN Bio, which has a tRNA suppressors approach to diseases of aging and logevity. Plus, a unique crypto financing angle to this story. Coverage brought to you by

Company News

May 14

Michael Torres talks about TMC Innovation, the biotech ecosystem in Houston, and founding companies

Michael Torres describes his work in Texas, co-founding ReCode, helping entrepreneurs in Houston, and founding a next-gen ADC company.

Bright Minds

Sep 22, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

Learn more

bottom of page

ASGCT 2026: Michael Torres isn't slowing down after selling his antibody-drug conjugate company to Eli Lilly. Here's his gene therapy play

Michael Torres talks about TMC Innovation, the biotech ecosystem in Houston, and founding companies

Follow BiotechTV

Sponsors

Sponsor Spotlight